ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Klas Therapeutics Limited

Klas Therapeutics Limited is an active company incorporated on 16 February 2021 with the registered office located in Belfast, County Down. Klas Therapeutics Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
NI676570
Private limited company
Northern Ireland Company
Age
4 years
Incorporated 16 February 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 15 February 2025 (8 months ago)
Next confirmation dated 15 February 2026
Due by 1 March 2026 (3 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 1 Mar28 Feb 2025 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 28 February 2026
Due by 30 November 2026 (1 year remaining)
Address
C/O Cleaver Fulton Rankin
50 Bedford Street
Belfast
BT2 7FW
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
People
Officers
4
Shareholders
6
Controllers (PSC)
1
PSC • Director • Northern Irish • Lives in Northern Ireland • Born in Aug 1979 • Senior Lecturer
Director • Professor • British • Lives in Northern Ireland • Born in Mar 1973
Director • University Director • Irish • Lives in Northern Ireland • Born in Nov 1972
Director • Consultant Dermatologist • British • Lives in England • Born in Sep 1977
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Sonotarg Limited
Professor John Callan and Director Timothy John Brundle are mutual people.
Active
Sisaf Ltd
Director Timothy John Brundle is a mutual person.
Active
Sonotarg Holdings Limited
Professor John Callan is a mutual person.
Active
Boom! INC
Director Timothy John Brundle is a mutual person.
Active
Inclutech Ltd
Director Timothy John Brundle is a mutual person.
Active
Efectis UK/Ireland Limited
Director Timothy John Brundle is a mutual person.
Active
Retinize Limited
Director Timothy John Brundle is a mutual person.
Active
Pulseai Ltd
Director Timothy John Brundle is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2025)
Period Ended
28 Feb 2025
For period 28 Feb28 Feb 2025
Traded for 12 months
Cash in Bank
£102.7K
Increased by £54.78K (+114%)
Turnover
Unreported
Same as previous period
Employees
4
Increased by 2 (+100%)
Total Assets
£199.61K
Increased by £140.21K (+236%)
Total Liabilities
-£279.7K
Increased by £146.64K (+110%)
Net Assets
-£80.09K
Decreased by £6.43K (+9%)
Debt Ratio (%)
140%
Decreased by 83.88% (-37%)
Latest Activity
Full Accounts Submitted
4 Months Ago on 17 Jun 2025
Confirmation Submitted
8 Months Ago on 25 Feb 2025
Dr Bridgeen Callan Details Changed
8 Months Ago on 24 Feb 2025
Full Accounts Submitted
1 Year 1 Month Ago on 12 Sep 2024
Justin Murphy Resigned
1 Year 6 Months Ago on 26 Apr 2024
Confirmation Submitted
1 Year 8 Months Ago on 26 Feb 2024
Mr Timothy John Brundle Appointed
1 Year 8 Months Ago on 7 Feb 2024
Full Accounts Submitted
1 Year 11 Months Ago on 30 Nov 2023
Confirmation Submitted
2 Years 8 Months Ago on 24 Feb 2023
Full Accounts Submitted
2 Years 10 Months Ago on 16 Dec 2022
Get Credit Report
Discover Klas Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 28 February 2025
Submitted on 17 Jun 2025
Confirmation statement made on 15 February 2025 with updates
Submitted on 25 Feb 2025
Director's details changed for Dr Bridgeen Callan on 24 February 2025
Submitted on 24 Feb 2025
Resolutions
Submitted on 18 Sep 2024
Statement of capital following an allotment of shares on 17 September 2024
Submitted on 17 Sep 2024
Total exemption full accounts made up to 29 February 2024
Submitted on 12 Sep 2024
Termination of appointment of Justin Murphy as a director on 26 April 2024
Submitted on 10 May 2024
Confirmation statement made on 15 February 2024 with updates
Submitted on 26 Feb 2024
Sub-division of shares on 7 February 2024
Submitted on 20 Feb 2024
Statement of capital following an allotment of shares on 7 February 2024
Submitted on 20 Feb 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year